Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company has commercial development and clinical supply agreement with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Show more...
FAQ
Nutriband 今天的股價是多少?▼
9WV.F 目前價格為 €2.82 EUR,過去 24 小時上漲了 +2.17%。在圖表上更密切關注 Nutriband 股價表現。
Nutriband 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Nutriband 的股票以代號 9WV.F 進行交易。
Nutriband 的股價在上漲嗎?▼
9WV.F 股票較上週下跌 -5.37%,本月下跌 -18.97%,過去一年 Nutriband 下跌 -30.2%。
Nutriband 的市值是多少?▼
今天 Nutriband 的市值為 34.33M
Nutriband 下一次財報日期是什麼時候?▼
Nutriband 將於 May 01, 2026 公布下一次財報。
Nutriband 去年的營收是多少?▼
Nutriband 去年的營收為 4.07MEUR。
Nutriband 去年的淨利是多少?▼
9WV.F 去年的淨收益為 -20.04MEUR。
Nutriband 位於哪個產業?▼
Nutriband從事於Health Care產業。
Nutriband 何時完成拆股?▼
Nutriband 上次拆股發生於 July 25, 2025,比例為 5:4。
Nutriband 的總部在哪裡?▼
Nutriband 的總部位於 US 的 Orlando。